<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30429980</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">2040-2511</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>9</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>MedChemComm</Title>                <ISOAbbreviation>Medchemcomm</ISOAbbreviation>            </Journal>            <ArticleTitle>A zwitterionic near-infrared dye linked TrkC targeting agent for imaging metastatic breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>1754-1760</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1039/c8md00190a</ELocationID>            <Abstract>                <AbstractText>Much effort has been devoted to targeting agents for imaging and chemotherapy of tumors in cancer research, but there remain significant unmet needs in that area. We have reported a series of preclinical TrkC targeting agents for diagnoses and treatment of metastatic breast cancer; however, with respect to optical imaging, there are limitations to the agents already disclosed. In this work, a TrkC targeting fragment was equipped with a zwitterionic cyanine dye to give a near-infrared probe for <i>in vivo</i> imaging of metastatic breast tumors, with excitation and emission wavelengths of 760 and 780 nm, respectively, and facilitate the aqueous dissolution of the final design. To our delight, the newly developed probe maintained the specific targeting to TrkC<sup>+</sup> 4T1 metastatic breast tumor cells as well as the TrkC<sup>+</sup> metastatic breast tumor tissue. Upon injection into 4T1-tumor-bearing mice, the tumor was visualized <i>in vivo</i> and <i>ex vivo</i> through the fluorescence signal of the probe. These data seem to encourage further investigations toward developing a TrkC targeting agent for the diagnosis of metastatic breast tumors.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Zhen</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Bioenergetics , Houston Methodist Research Institute , Houston , TX 77030 , USA . Email: zli@houstonmethodist.org.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Usama</LastName>                    <ForeName>Syed Muhammad</ForeName>                    <Initials>SM</Initials>                    <Identifier Source="ORCID">0000-0002-7487-1568</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry , Texas A &amp; M University , Box 30012 , College Station , TX 77842 , USA . Email: burgess@tamu.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Feng</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Bioenergetics , Houston Methodist Research Institute , Houston , TX 77030 , USA . Email: zli@houstonmethodist.org.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Burgess</LastName>                    <ForeName>Kevin</ForeName>                    <Initials>K</Initials>                    <Identifier Source="ORCID">0000-0001-6597-1842</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry , Texas A &amp; M University , Box 30012 , College Station , TX 77842 , USA . Email: burgess@tamu.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Zheng</ForeName>                    <Initials>Z</Initials>                    <Identifier Source="ORCID">0000-0001-6118-9175</Identifier>                    <AffiliationInfo>                        <Affiliation>Center for Bioenergetics , Houston Methodist Research Institute , Houston , TX 77030 , USA . Email: zli@houstonmethodist.org.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>03</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Medchemcomm</MedlineTA>            <NlmUniqueID>101531525</NlmUniqueID>            <ISSNLinking>2040-2503</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Chem Commun (Camb). 2015 Jul 7;51(53):10664-7</RefSource>                <PMID Version="1">26051677</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Maedica (Buchar). 2013 Mar;8(1):43-8</RefSource>                <PMID Version="1">24023598</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chem Commun (Camb). 2015 Mar 7;51(19):3989-92</RefSource>                <PMID Version="1">25664357</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2013 Oct 10;56(19):7608-14</RefSource>                <PMID Version="1">24063347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Talanta. 2012 Apr 15;92:45-52</RefSource>                <PMID Version="1">22385806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2015 May 28;58(10):4348-56</RefSource>                <PMID Version="1">25923454</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Theranostics. 2013 Aug 21;3(9):692-702</RefSource>                <PMID Version="1">24019854</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2</RefSource>                <PMID Version="1">18432775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurosci. 2001 Nov 15;21(22):8915-30</RefSource>                <PMID Version="1">11698603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2013 Feb;31(2):148-53</RefSource>                <PMID Version="1">23292608</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2014 Aug;14(4):235-40</RefSource>                <PMID Version="1">24703317</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Chem Biol. 2003 Oct;7(5):626-34</RefSource>                <PMID Version="1">14580568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chem Soc Rev. 2017 Apr 18;46(8):2237-2271</RefSource>                <PMID Version="1">28319221</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Med Chem. 2016;23(5):483-97</RefSource>                <PMID Version="1">26695513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2012 Mar;33(7):2230-9</RefSource>                <PMID Version="1">22182749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Res Rev. 2016 May;36(3):494-575</RefSource>                <PMID Version="1">26992114</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2006 Sep;6(9):714-27</RefSource>                <PMID Version="1">16929325</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2010 Sep;31(25):6612-7</RefSource>                <PMID Version="1">20542559</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Comp Neurol. 1995 Jun 5;356(3):387-97</RefSource>                <PMID Version="1">7642800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Discov. 2015 Jan;5(1):25-34</RefSource>                <PMID Version="1">25527197</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Angew Chem Int Ed Engl. 2011 Jul 4;50(28):6258-63</RefSource>                <PMID Version="1">21656624</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2001 Mar 15;344(11):783-92</RefSource>                <PMID Version="1">11248153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medchemcomm. 2017 Sep 14;8(10):1946-1952</RefSource>                <PMID Version="1">30108715</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 Feb 15;69(4):1268-72</RefSource>                <PMID Version="1">19176373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 2010 Jul;65(7):500-16</RefSource>                <PMID Version="1">20541650</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>ACS Med Chem Lett. 2016 Dec 09;8(2):179-184</RefSource>                <PMID Version="1">28197308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2015 Oct 29;373(18):1685-7</RefSource>                <PMID Version="1">26510017</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Chem. 2015 Mar 26;58(6):2845-54</RefSource>                <PMID Version="1">25711712</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2010 Nov;31(11):1939-47</RefSource>                <PMID Version="1">20802235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Pharm. 2015 Jan 5;12(1):212-22</RefSource>                <PMID Version="1">25487316</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>08</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30429980</ArticleId>            <ArticleId IdType="doi">10.1039/c8md00190a</ArticleId>            <ArticleId IdType="pii">c8md00190a</ArticleId>            <ArticleId IdType="pmc">PMC6194490</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>